Company profile: Evozyne
1.1 - Company Overview
Company description
- Provider of generative AI-driven protein design and engineering solutions for therapeutic discovery and drug development, including ProT-VAE (co-developed with NVIDIA) to design therapeutic proteins, protein engineering for rare diseases (in partnership with Takeda), evolutionary deep learning to create novel proteins, and computational chemistry to optimize protein stability and function.
Products and services
- Protein Engineering for Rare Diseases: An industrial-grade partnership with Takeda that engineers proteins to tackle rare disease treatment challenges, aligned with therapeutic discovery and drug development objectives
- ProT-VAE: A custom-engineered platform developed with NVIDIA that architects therapeutic proteins, enhancing design quality and accelerating development speed for drug development programs
- Evolutionary Deep Learning: A research-grade approach that utilizes principles of evolution to guide the creation of novel proteins for addressing therapeutic challenges in drug development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Evozyne
PMOD Technologies
HQ: Switzerland
Website
- Description: Provider of software quantification tools for biomedical imaging in humans and animals. PMOD software originated in 1993, developed at the University Hospital PET Center in Zurich when PET was mainly a research tool, and was adopted by the PET community.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PMOD Technologies company profile →
RxS
HQ: United States
Website
- Description: Provider of end-to-end multi-channel sample management solutions, including LinkedRx for compliant management of pharmaceutical samples across hand-carry and direct-to-practitioner channels; TeleTargetRx contact center CRM for inside sales and sample requests; SampleCentral eSampling portal for healthcare professionals; RxS Engage telesampling and support services; and ClientConnect multi-channel reporting and analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RxS company profile →
Overwatch Research
HQ: United Kingdom
Website
- Description: Provider of all-in-one experimental tracking software for in vivo research, including Benchling In Vivo for study design and review, in-life data capture linked to treatments and groups, multi-parameter randomization, flexible task management and scheduling, and real-time data visualization from a centralized database to save time, reduce error, and increase collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Overwatch Research company profile →
TetraScience
HQ: United States
Website
- Description: Provider of an R&D cloud data platform for life sciences and drug discovery, offering the Tetra Scientific Data and AI Cloud to manage and analyze scientific data; data replatforming for lab data automation; AI-driven outcomes across the scientific value chain; data engineering with scientific taxonomies and ontologies; GxP-compliant, secure, traceable data management; and analytics and visualization tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TetraScience company profile →
SmartSeq
HQ: Italy
Website
- Description: Provider of the Amplicon Suite software and integrated NGS data analysis tools, enabling analysis, visualization, and exploration of data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SmartSeq company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Evozyne
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Evozyne
2.2 - Growth funds investing in similar companies to Evozyne
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Evozyne
4.2 - Public trading comparable groups for Evozyne
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →